查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
楔壓導管市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1273527

楔壓導管市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Wedge Pressure Catheter Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在預測期內，楔壓導管市場的複合年增長率為 6.5%。

全球 COVID-19 病例數的增加和封鎖情況最初對市場產生了重大影響，因為治療、診斷和手術等服務被暫停以防止 COVID-19 的傳播。稻田。 COVID-19 對心血管的影響是驚人的和多方面的。 美國國家醫學圖書館 2020 年 12 月發表的一項研究發現，COVID-19 患者的肺動脈楔壓高於急性呼吸窘迫綜合徵 (ARDS) 患者，並且與肺順應性呈負相關。 因此，在 COVID-19 中，由於凝血障礙和伴隨的靜脈和動脈血栓栓塞對循環系統的廣泛影響，需要楔形壓力導管。 此外，自 COVID-19 以來，全球限制已經放鬆，疾病篩查服務已經恢復，因此在當前情況下市場增長正在穩定。

被診斷患有心血管疾病和中風的患者數量不斷增加是推動市場增長的主要因素。 根據世界中風組織（WSO）2022年公佈的數據，約有1200萬人（12224551人）經歷過中風。 該組織表示，每年有超過 1220 萬例新中風，在全球範圍內，25 歲以上的人中有四分之一在其一生中會經歷中風。 因此，全球患者負擔的增加正在增加對外科手術的需求，預計這將在預測期內進一步推動楔壓導管市場的增長。

此外，根據英國心臟基金會 2022 年 1 月發布的一項研究，英國約有 760 萬心髒病患者。 英國平均每天有 460 例 CVD 死亡，或每三分鐘一例。 心血管疾病負擔的增加推動了對可降低心力衰竭相關死亡率的創新技術的需求，這在研究期間增加了對楔形壓力導管的需求。

心髒病，包括冠心病、高血壓和中風，是美國的頭號死因。 此外，由於為開發治療各種心髒病和中風管理的新技術而進行的研發活動不斷增加，預計在預測期內將實現盈利增長。

但是，楔壓導管的問題以及新興市場缺乏訓練有素的醫務人員可能會減緩市場增長。

楔壓導管市場趨勢

從應用來看，肺動脈段預計將佔據最大的市場份額

近年來，肺動脈部分的收入份額最大，預計在預測期內仍將如此。 這種優勢源於心血管疾病的高患病率以及主要參與者針對不同條件推出的不同類型產品的可用性，導致需求增加。 此外，用於監測動脈壓的楔形壓力導管的迅速採用預計將增加製造商的需求並推動全球市場。

根據 Pulmonary Circulation 於 2022 年 1 月發表的一篇文章，肺動脈高壓 (PAH) 的特徵是血管重塑導致肺孔阻力增加。 患病率範圍為每 100,000 人 0.4 至 1.4 人。 此外，根據 2021 年 8 月發布的 WHO Key Facts，全世界有 12.8 億 30-79 歲的成年人患有高血壓，其中大多數（三分之二）生活在低收入和中等收入國家。 非傳染性疾病的全球目標之一是在 2010 年至 2030 年間將高血壓患病率降低 33%。 肺動脈高壓患病率的增加和老年人口的增加是推動肺動脈段市場增長的主要因素。

根據世界衛生組織的數據，到 2050 年，世界上 60 歲及以上的人口將比上一年翻一番，達到 22%。 肺動脈高壓的症狀包括呼吸急促（呼吸困難）、胸痛和昏厥，尤其是在運動期間。 由於老年人口越來越多，與肺動脈高壓有關的並發症也越來越多。 所有這些因素都在推動這一細分市場的增長。

楔形壓力導管市場-IMG1

北美在市場上占主導地位，預計在預測期內也會如此。

在整個預測期內，預計北美將主導整個楔壓導管市場。 北美楔壓導管市場增長的主要驅動因素是心血管疾病負擔的增加、技術採用的增加、產品批准的增加、投資的增加以及政府的舉措。

根據美國疾病預防控制中心的一份報告（2021 年更新的統計數據），美國人每 40 秒就有可能心髒病發作一次。 因此，患有心血管疾病的人的負擔很高，對楔形壓力導管的需求預計會增加。 因此，預計將推動該地區的市場。

此外，提高認識、高診斷率和政府支持措施預計將在預測期內進一步推動市場增長。 根據美國疾病控制與預防中心 2022 年 8 月發布的數據，百萬心臟計劃是一項旨在在五年內預防 100 萬例心髒病發作和中風的國家計劃。 它側重於實施一小組以證據為基礎的優先事項和目標，以改善每個人的心血管健康。 另一個例子是世衛組織的全球 HEARTS 倡議，該倡議促進 CVD 預防，包括加強煙草控制、減少膳食鹽攝入量、增加身體活動、消除工業生產飲食中的反式脂肪以及管理 CVD 風險。支持各國加強行動

因此，上述因素預計將在預測期內推動該地區的市場增長。

楔形壓力導管市場-IMG2

楔形壓力導管行業概況

楔壓導管市場競爭適中，由幾家大型企業組成。 一些公司正在擴大其市場地位，而另一些公司則採取各種戰略，如收購、兼併和推出新產品，以保持其市場份額。 Alpha Medical Instruments LLC、Advanced Lifesciences Pvt. Ltd.、Teleflex Incorporated、DeRoyal Industries 和 ICU Medical Inc. 等公司佔據了重要的市場份額。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

內容

第一章介紹

  • 調查假設和市場定義
  • 本次調查的範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 增加心髒病和中風患者的負擔
    • 啟動研發活動，開發心髒病和中風管理新技術
  • 市場製約因素
    • 與楔壓導管相關的並發症
    • 新興經濟體缺乏熟練的醫療保健專業人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模）

  • 按材料
    • 聚氨酯
    • 尼龍
    • 其他材料
  • 通過使用
    • 肺動脈
    • 中央靜脈
    • 心室
    • 其他用途
  • 最終用戶
    • 醫院
    • 專科門診
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Alpha Medical Instruments LLC
    • Advanced Lifesciences Pvt Ltd.
    • Teleflex Incorporated
    • DeRoyal Industries
    • ICU Medical Inc
    • Nolato AB
    • Edwards Lifesciences
    • B. Braun Melsungen AG
    • Merit Medical Systems Inc.

第7章 市場機會與將來動向

簡介目錄
Product Code: 67671

The wedge pressure catheter market is expected to register a CAGR of 6.5% over the forecast period.

The rising COVID-19 cases across the world and the lockdown situation had a significant impact on the market, initially due to on-hold services such as treatment, diagnostic, and surgical services to prevent the spread of COVID-19. The impact of COVID-19 on the cardiovascular system was prominent and multifaceted. As per the study published in December 2020 by the National Library of Medicine, pulmonary artery wedge pressure was higher in COVID-19 patients than in acute respiratory distress syndrome (ARDS) patients and inversely related to lung compliance. Therefore, there was a need for wedge pressure catheters during COVID-19, as they had wide-ranging effects on the cardiovascular system due to coagulopathy and resultant venous and arterial thromboembolism. Furthermore, market growth is stabilizing in the current scenario following COVID-19, as global restrictions were eased and disease screening services were resumed.

The increasing number of patients diagnosed with cardiovascular diseases and stroke is a major factor driving market growth.According to data published by the World Stroke Organization (WSO) in 2022, about 12 million (12,224,551) people experienced a stroke. The organization stated that there are more than 12.2 million new strokes each year, and globally, one in four people after age 25 experiences a stroke in their lifetime. Hence, the increasing burden of patients globally is expected to drive the demand for surgical procedures, which is further expected to drive the wedge pressure catheter market growth over the forecast period.

Moreover, according to a study published by the British Heart Foundation in January 2022, there were approximately 7.6 million people with heart disease in the United Kingdom. An average of 460 deaths per day, or one death every three minutes, happen in the United Kingdom due to CVDs. Due to the rising burden of cardiovascular diseases, there is an increasing demand for innovative technologies that can decrease the mortality rates associated with heart failure, thereby increasing the demand for wedge pressure catheters during the study period.

Heart diseases like coronary heart disease, hypertension, and stroke are ranked as the highest cause of death in the United States. Furthermore, an increase in research and development activities to develop novel technologies to treat various cardiac disorders and stroke management is expected to see profitable growth during the forecast period.

But problems with the wedge pressure catheter and a lack of trained medical professionals in emerging markets are likely to slow the market's growth.

Wedge Pressure Catheter Market Trends

Pulmonary Artery Segment by Application is Expected to Hold the Largest Market Share

The pulmonary artery segment accounted for the largest revenue share in recent years and is expected to do so over the forecast period. This dominance is owing to the increased demand due to the high incidence rate of cardiovascular diseases and the availability of various types of products launched by the key players that are suitable for various disease conditions. Furthermore, the rapid increase in the adoption of wedge pressure catheters for monitoring arterial pressure is also expected to increase the demand for manufacturers, which will drive the global market.

As per an article published in January 2022 by Pulmonary Circulation, pulmonary arterial hypertension (PAH) is characterized by increased resistance in the pulmonary arterioles because of remodeled blood vessels. The prevalence ranged from 0.4 to 1.4 per 100,000 people. Moreover, according to WHO key facts published in August 2021, an estimated 1.28 billion adults worldwide aged 30-79 years have hypertension, with most (two-thirds) living in low- and middle-income countries. One of the global targets for non-communicable diseases is to reduce the prevalence of hypertension by 33% between 2010 and 2030. The increasing prevalence of pulmonary arterial hypertension and the growing geriatric population are the main factors that are boosting the growth of the pulmonary artery segment's market.

According to the WHO, by 2050, the world's population over 60 will nearly double to 22% from the previous year. The symptoms of pulmonary arterial hypertension include shortness of breath (dyspnea), especially during exercise, chest pain, and fainting. The increase in the number of geriatrics leads to consequences that, in several cases, include complications related to pulmonary arterial hypertension. All these factors boost the growth of the segment.

Wedge Pressure Catheter Market - IMG1

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall wedge pressure catheters market throughout the forecast period. The primary driving factors for the growth of the North American wedge pressure catheter market are the growing burden of cardiovascular diseases, the rising adoption of technologies, increasing product approvals, increasing investments, and initiatives taken by the government.

According to a report by the United States CDC (statistics updated in 2021), every 40 seconds, an American may have a heart attack. Thus, there is a high burden of people suffering from cardiovascular diseases, which are expected to increase the demand for wedge pressure catheters. This is expected to drive the market in the region.

Moreover, increased awareness, a high diagnosis rate, and supportive government initiatives are further expected to boost the growth of the market over the forecast period. According to Centers for Disease Control and Prevention data published in August 2022, Million Hearts is a national initiative to prevent 1 million heart attacks and strokes within 5 years. It focuses on implementing a small set of evidence-based priorities and targets that can improve cardiovascular health for all. Another instance is the WHO global HEARTS Initiative, which supports countries strengthening actions to prevent CVD, such as enhanced tobacco control, dietary salt reduction, increasing physical activity, the elimination of industrially produced dietary trans-fats, and the management of CVD risks.

Therefore, the above-mentioned factors are expected to drive market growth in the region during the forecast period.

Wedge Pressure Catheter Market - IMG2

Wedge Pressure Catheter Industry Overview

The Wedge Pressure Catheter Market is moderately competitive and consists of several major players. Some of the companies are expanding their market position, while others are adopting various strategies such as acquisitions, mergers, and introducing new products to maintain their market share. Companies like Alpha Medical Instruments LLC, Advanced Lifesciences Pvt. Ltd., Teleflex Incorporated, DeRoyal Industries, and ICU Medical Inc., among others, hold a substantial market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiac Diseases and Stroke Cases
    • 4.2.2 Growing R&D Activities to Develop Novel Technologies in Cardiac Stroke Management
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with the Wedge Pressure Catheters
    • 4.3.2 Lack of Skilled Healthcare Professionals in Emerging Markets
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Material
    • 5.1.1 Polyurethane
    • 5.1.2 Nylon
    • 5.1.3 Other Materials
  • 5.2 By Application
    • 5.2.1 Pulmonary Artery
    • 5.2.2 Central Venous
    • 5.2.3 Ventricular
    • 5.2.4 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Specialty Clinics
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alpha Medical Instruments LLC
    • 6.1.2 Advanced Lifesciences Pvt Ltd.
    • 6.1.3 Teleflex Incorporated
    • 6.1.4 DeRoyal Industries
    • 6.1.5 ICU Medical Inc
    • 6.1.6 Nolato AB
    • 6.1.7 Edwards Lifesciences
    • 6.1.8 B. Braun Melsungen AG
    • 6.1.9 Merit Medical Systems Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS